Search
Close this search box.

Randomised Trial to Compare the Rates of Disease-Free Survival in Margine-Positive Patients After Radical Prostatectomy With or Without Adjuvant Post-Operative Radiotherapy

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Related Post

Trek4TROG team 2024 in Blue Mountains
13 November, 2024

Trek4TROG team rise to Blue Mountains challenge

November 2024: Congratulations to the Trek4TROG team for successfully

24 October, 2024

Promising new results from RAIDER trial published

24 October 2024: Newly published findings from the TROG